{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T06:02:47Z","timestamp":1794204167637,"version":"4.8.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["Scholar of CPRIT Established Investigator Award RR190108"],"award-info":[{"award-number":["Scholar of CPRIT Established Investigator Award RR190108"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xcrm.2026.103010","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:36:40Z","timestamp":1787848600000},"page":"103010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["RET-driven osteoprotegerin expression links medullary thyroid cancer to osteoblastic bone metastases"],"prefix":"10.1016","volume":"7","author":[{"given":"Rozita","family":"Bagheri-Yarmand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0888-5117","authenticated-orcid":false,"given":"Gabriel M.","family":"Pagnotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Avila","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Trupti Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Martinez","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade M.","family":"Moehle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaashmin S.","family":"Jebaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhai","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian H.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Roland L.","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue-Hwa","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi I.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven I.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7026-402X","authenticated-orcid":false,"given":"Theresa A.","family":"Guise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.103010_bib1","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1210\/jc.2016-2815","article-title":"Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma","volume":"101","author":"Xu","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xcrm.2026.103010_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2020.100282","article-title":"Bone metastases in thyroid cancer","volume":"21","author":"I\u00f1iguez-Ariza","year":"2020","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.xcrm.2026.103010_bib3","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143764","article-title":"Exploiting bone niches: progression of disseminated tumor cells to metastasis","volume":"131","author":"Muscarella","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.103010_bib4","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa077","article-title":"Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic Morphology","volume":"105","author":"Vogel","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xcrm.2026.103010_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","article-title":"The amazing osteocyte","volume":"26","author":"Bonewald","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.xcrm.2026.103010_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00774-003-0439-1","article-title":"The mechanism of osteoclast differentiation from macrophages: possible roles of T lymphocytes in osteoclastogenesis","volume":"21","author":"Udagawa","year":"2003","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.xcrm.2026.103010_bib7","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.2741\/2296","article-title":"Signaling and transcriptional regulation in osteoblast commitment and differentiation","volume":"12","author":"Huang","year":"2007","journal-title":"Front. Biosci."},{"key":"10.1016\/j.xcrm.2026.103010_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","article-title":"Role and mechanism of action of sclerostin in bone","volume":"96","author":"Delgado-Calle","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.xcrm.2026.103010_bib9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood-2008-03-145169","article-title":"The role of Dickkopf-1 in bone development, homeostasis, and disease","volume":"113","author":"Pinzone","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.103010_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2022.102287","article-title":"Fibroblast growth factor 23 inhibits osteogenic differentiation and mineralization of chicken bone marrow mesenchymal stem cells","volume":"102","author":"Lyu","year":"2023","journal-title":"Poult. Sci."},{"key":"10.1016\/j.xcrm.2026.103010_bib11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41420-022-01042-0","article-title":"The roles of osteoprotegerin in cancer, far beyond a bone player","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.xcrm.2026.103010_bib12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrendo.2016.11","article-title":"A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma","volume":"12","author":"Romei","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.xcrm.2026.103010_bib13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1200\/JCO.19.02551","article-title":"State-of-the-Art Strategies for Targeting RET-Dependent Cancers","volume":"38","author":"Subbiah","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.103010_bib14","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.molcel.2014.01.015","article-title":"Oncogenic RET kinase domain mutations perturb the autophosphorylation trajectory by enhancing substrate presentation in trans","volume":"53","author":"Plaza-Menacho","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2026.103010_bib15","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.xcrm.2026.103010_bib16","first-page":"1241","article-title":"Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma","volume":"56","author":"Marsh","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103010_bib17","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1210\/endrev\/bnad013","article-title":"Medullary Thyroid Cancer: Updates and Challenges","volume":"44","author":"Gild","year":"2023","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.xcrm.2026.103010_bib18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.bone.2015.08.003","article-title":"Rapid modification of the bone microenvironment following short-term treatment with Cabozantinib in vivo","volume":"81","author":"Haider","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.xcrm.2026.103010_bib19","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/annonc\/mdy137","article-title":"Selective RET kinase inhibition for patients with RET-altered cancers","volume":"29","author":"Subbiah","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2026.103010_bib20","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa2309719","article-title":"Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer","volume":"389","author":"Hadoux","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.103010_bib21","doi-asserted-by":"crossref","first-page":"ra18","DOI":"10.1126\/scisignal.aac4374","article-title":"ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2alpha kinases","volume":"9","author":"Kline","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.xcrm.2026.103010_bib22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1158\/1535-7163.MCT-20-0386","article-title":"ONC201 Shows Potent Anticancer Activity Against Medullary Thyroid Cancer via Transcriptional Inhibition of RET, VEGFR2, and IGFBP2","volume":"20","author":"Bagheri-Yarmand","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.xcrm.2026.103010_bib23","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1158\/2159-8290.CD-18-0338","article-title":"Precision Targeted Therapy with BLU-667 for RET-Driven Cancers","volume":"8","author":"Subbiah","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.103010_bib24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2011.35.5040","article-title":"Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial","volume":"30","author":"Wells","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.103010_bib25","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/annonc\/mdx479","article-title":"Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma","volume":"28","author":"Schlumberger","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2026.103010_bib26","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.4110\/in.2018.18.e8","article-title":"Regulation of Osteoclast Differentiation by Cytokine Networks","volume":"18","author":"Amarasekara","year":"2018","journal-title":"Immune Netw."},{"key":"10.1016\/j.xcrm.2026.103010_bib27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm1519","article-title":"NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF","volume":"13","author":"Park","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103010_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020326","article-title":"GP130 Cytokines in Breast Cancer and Bone","volume":"12","author":"Omokehinde","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2026.103010_bib29","doi-asserted-by":"crossref","first-page":"E992","DOI":"10.1073\/pnas.1718009115","article-title":"HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice","volume":"115","author":"Devignes","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103010_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.574667","article-title":"The Role of the CXCL12\/CXCR4\/CXCR7 Chemokine Axis in Cancer","volume":"11","author":"Shi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.103010_bib31","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.bbrc.2020.02.054","article-title":"IL-17 promotes osteoblast differentiation, bone regeneration, and remodeling in mice","volume":"524","author":"Kim","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.xcrm.2026.103010_bib32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.arcmed.2003.09.007","article-title":"Mesenchymal stem cells","volume":"34","author":"Short","year":"2003","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.xcrm.2026.103010_bib33","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jcb.20719","article-title":"Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6","volume":"98","author":"Friedman","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.xcrm.2026.103010_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103010_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103010_bib36","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2026.103010_bib37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1006\/bbrc.1998.8697","article-title":"Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor\/osteoprotegerin","volume":"247","author":"Mizuno","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.xcrm.2026.103010_bib38","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1158\/1078-0432.CCR-07-5019","article-title":"OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer","volume":"14","author":"De Toni","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103010_bib39","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1158\/0008-5472.CAN-07-6052","article-title":"A novel RET kinase-beta-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma","volume":"68","author":"Gujral","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103010_bib40","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.7150\/thno.36818","article-title":"ATF4 destabilizes RET through nonclassical GRP78 inhibition to enhance chemosensitivity to bortezomib in human osteosarcoma","volume":"9","author":"Luo","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.xcrm.2026.103010_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/jmedgenet-2019-106734","article-title":"Germline RET variants underlie a subset of paediatric osteosarcoma","volume":"58","author":"Kovac","year":"2021","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.xcrm.2026.103010_bib42","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1158\/1078-0432.CCR-17-0528","article-title":"RET Signaling in Prostate Cancer","volume":"23","author":"Ban","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103010_bib43","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13058-023-01622-7","article-title":"RET signaling in breast cancer therapeutic resistance and metastasis","volume":"25","author":"Pecar","year":"2023","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103010_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/biom10020337","article-title":"Pathological Crosstalk between Metastatic Breast Cancer Cells and the Bone Microenvironment","volume":"10","author":"Zarrer","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.xcrm.2026.103010_bib45","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/emmm.201302625","article-title":"Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells","volume":"5","author":"Gattelli","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.xcrm.2026.103010_bib46","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.xcrm.2026.103010_bib47","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/jc.2009-1485","article-title":"Medullary thyroid carcinoma cell lines contain a self-renewing CD133+ population that is dependent on ret proto-oncogene activity","volume":"95","author":"Zhu","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xcrm.2026.103010_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/ERC-09-0292","article-title":"The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells","volume":"18","author":"Vitagliano","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.xcrm.2026.103010_bib49","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0165-4608(94)00185-E","article-title":"Cytogenetic characterization of three human and three rat medullary thyroid carcinoma cell lines","volume":"80","author":"Cooley","year":"1995","journal-title":"Cancer Genet. Cytogenet."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:15:54Z","timestamp":1789503354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126004271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2666379126004271"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103010","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RET-driven osteoprotegerin expression links medullary thyroid cancer to osteoblastic bone metastases","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103010"}}